PDSB Earnings & Financial Statements
PDS Biotechnology Corporation
$1.30
-$0.11(-7.80%)
55
Overall
60
Value
91
Tech
15
Quality
Market Cap
$102.19M
Volume
10.19M
52W Range
$0.20 - $1.55
Target Price
$4.17
PDSB earnings and financial statements: PDS Biotechnology Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
PDSB Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$31.54M | -$36.32M | -$43.05M | -$41.67M | -$21.44M |
| EBITDA | -$28.74M | -$32.59M | -$39.29M | -$40.74M | -$21.43M |
| Net income | -$34.50M | -$37.61M | -$42.94M | -$40.85M | -$16.92M |
| EPS (diluted) | $-0.74 | $-1.03 | $-1.39 | $-1.43 | $-0.66 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $30.49M | $45.36M | $59.39M | $77.01M | $67.20M |
| Total liabilities | $21.24M | $26.35M | $33.26M | $33.01M | $3.99M |
| Shareholders’ equity | $9.25M | $19.00M | $26.13M | $44.00M | $63.21M |
| Cash and equivalents | $26.70M | $41.69M | $56.56M | $73.82M | $65.24M |
| Long-term debt | $11.76M | $9.27M | $19.63M | $23.18M | $231.4K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$27.75M | -$35.03M | -$33.64M | -$25.71M | -$12.49M |
| Capital expenditure | - | -$29.0K | - | - | - |
| Free cash flow | -$27.75M | -$35.06M | -$33.64M | -$25.71M | -$12.49M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PDSB | $1.30 | -7.8% | 10.19M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get PDS Biotechnology Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW